NASDAQ: SNCE - Science 37 Holdings, Inc.

Rentabilität für sechs Monate: 0%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Science 37 Holdings, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.

weitere details
The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2020-11-20
ISIN US8086441081
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.science37.com
Цена ао 5.75
Preisänderung pro Tag: 0% (5.75)
Preisänderung pro Woche: 0% (5.75)
Preisänderung pro Monat: 0% (5.75)
Preisänderung über 3 Monate: 0% (5.75)
Preisänderung über sechs Monate: 0% (5.75)
Preisänderung pro Jahr: 0% (5.75)
Preisänderung über 3 Jahre: +5.89% (5.43)
Preisänderung seit Jahresbeginn: 0% (5.75)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0.6789 10
P/BV 0.489 10
P/E 0 0
EV/EBITDA 0.4243 10
Gesamt: 6.25

Effizienz

Name Bedeutung Grad
ROA, % -26.33 0
ROE, % -46.57 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.0093 10
Gesamt: 9.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 154.27 10
Rentabilität Ebitda, % 426.07 10
Rentabilität EPS, % 11478.95 10
Gesamt: 10
Weitere Details

Institutionen Volumen Aktie, %
Redmile Group, LLC 990412 0.83
Kent Lake Capital, LLC 278560 0.23
Glynn Capital Management Llc 176992 0.15
Russell Investments Group, Ltd. 169696 0.14
Vanguard Group Inc 160367 0.13
Alphabet Inc. 160364 0.13
MIC Capital Management UK LLP 117295 0.1
Alyeska Investment Group, L.P. 88319 0.07
Citadel Advisors Llc 67631 0.06
Samsara BioCapital, LLC 45000 0.04



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. David Coman CEO & Director 796.13k 1970 (55 Jahre)
Ms. Christine A. Pellizzari J.D. Chief Legal & Human Resources Officer and Secretary 521.58k 1968 (57 Jahre)
Ms. Darcy Forman Chief Delivery Officer 550.58k 1976 (49 Jahre)
Mr. Mike Zaranek Chief Financial Officer N/A 1971 (54 Jahr)
Irena Lambridis VP and Head of Quality Assurance & Compliance N/A
Ms. Margie Gimbel Kooman Vice President of Marketing & Communications N/A
Mr. Drew Bustos Chief Strategy & Marketing Officer N/A
Mr. Jonathan Cotliar M.D. Chief Medical Officer 486.6k 1972 (53 Jahr)
Mr. Michael Shipton Chief Commercial Officer N/A 1972 (53 Jahr)
Mr. Tyler Van Horn VP of Corporate Strategy & Chief of Staff N/A

Adresse: United States, Research Triangle Park. NC, 800 Park Offices Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.science37.com